ADORA3
Adenosine receptor A3
Also known as: A3AR, AA3R_HUMAN, AD026
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P0DMS8
- Gene
- ADORA3
- Ensembl
- ENSG00000282608
- Chromosome
- 1
- Canonical length
- 318 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a protein that belongs to the family of adenosine receptors, which are G-protein-coupled receptors that are involved in a variety of intracellular signaling pathways and physiological functions. The receptor encoded by this gene mediates a sustained cardioprotective function during cardiac ischemia, it is involved in the inhibition of neutrophil degranulation in neutrophil-mediated tissue injury, it has been implicated in both neuroprotective and neurodegenerative effects, and it may also mediate both cell proliferation and cell death. Alternative splicing results in multiple transcript variants. This gene shares its 5' terminal exon with some transcripts from overlapping GeneID:57413, which encodes an immunoglobulin domain-containing protein. [provided by RefSeq, Nov 2014]
Canonical amino-acid sequenceUniProt
318 residues, UniProt reviewed canonical sequence.
>P0DMS8|ADORA3
1 MPNNSTALSL ANVTYITMEI FIGLCAIVGN VLVICVVKLN PSLQTTTFYF IVSLALADIA
61 VGVLVMPLAI VVSLGITIHF YSCLFMTCLL LIFTHASIMS LLAIAVDRYL RVKLTVRYKR
121 VTTHRRIWLA LGLCWLVSFL VGLTPMFGWN MKLTSEYHRN VTFLSCQFVS VMRMDYMVYF
181 SFLTWIFIPL VVMCAIYLDI FYIIRNKLSL NLSNSKETGA FYGREFKTAK SLFLVLFLFA
241 LSWLPLSIIN CIIYFNGEVP QLVLYMGILL SHANSMMNPI VYAYKIKKFK ETYLLILKAC
301 VVCHPSDSLD TSIEKNSELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADORA3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 20 nTPM
- adrenal gland: 14 nTPM
- choroid plexus: 10 nTPM
- midbrain: 9.9 nTPM
- small intestine: 8.9 nTPM
- cerebral cortex: 6.5 nTPM
Single-cell type
- late spermatids: 4.7 nCPM
- early spermatids: 2.9 nCPM
- mast cells: 1.2 nCPM
- epididymal efferent duct ciliated cells: 0.4 nCPM
- microglia: 0.4 nCPM
- macrophages: 0.3 nCPM
Immune cell
- eosinophil: 603 nTPM
- myeloid DC: 15 nTPM
- basophil: 10 nTPM
- classical monocyte: 8.1 nTPM
- intermediate monocyte: 5.6 nTPM
- plasmacytoid DC: 3 nTPM
Brain region
- white matter: 36 nTPM
- thalamus: 26 nTPM
- medulla oblongata: 23 nTPM
- spinal cord: 18 nTPM
- pons: 16 nTPM
- hypothalamus: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.21
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of adenylate cyclase activity
- G protein-coupled adenosine receptor signaling pathway
- inflammatory response
- negative regulation of cell migration
- negative regulation of cell population proliferation
- negative regulation of NF-kappaB transcription factor activity
- presynaptic modulation of chemical synaptic transmission
- regulation of heart contraction
- regulation of norepinephrine secretion
- response to wounding
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADORA3 as an antibody target. Whether an autoantibody or antibody against ADORA3 could matter depends on whether native ADORA3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADORA3 is annotated at the cell surface, where native ADORA3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADORA3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...